3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Myeloid
1
Dermatologic
1
CNS
1
Conditions
Glioblastoma
6
Neuroblastoma
5
Central Nervous System Neoplasms
5
Gliosarcoma
4
Medulloblastoma
3
Glioma
3
Brain Neoplasms
3
Sarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Pinealoma
2
Ependymoma
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Pyloric Stenosis, Hypertrophic
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neurofibroma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Lymphoma
1
Leukemia
1
Histiocytosis, Langerhans-Cell
1
Carcinoma
1
Brainstem Glioma
1
Astrocytoma
1
Interventions
Sirolimus
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Automobiles
3
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Stem Cell Transplantation
2
Mesna
2
Immunotherapy
2
Gemcitabine
2
Etoposide
2
Carboplatin
2
Busulfan
2
vorasidenib
1
trametinib
1
tozuleristide
1
sonidegib
1
sodium thiosulfate
1
ripretinib
1
ribociclib
1
pegylated granulocyte colony-stimulating factor
1
lutetium Lu 177 dotatate
1
interferon gamma-1b
1
fludarabine phosphate
1
Watchful Waiting
1
Vorinostat
1
Ursodeoxycholic Acid
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Celecoxib
×
CNS
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled